Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Ho

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Cardiovascular Research|July 24, 2020
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) studyKenneth Mangion, Andrew Morrow, Catherine Bagot, et al.
The Lancet. Microbe|June 8, 2021
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort studyClark D Russell, Cameron J Fairfield, Thomas M Drake, et al.
BMJ (Clinical Research Ed.)|May 24, 2020
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyAnnemarie B Docherty, Ewen M Harrison, Christopher A Green, et al.
The Lancet. Digital Health|March 26, 2022
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort studyFiina Närhi, S Ramani Moonesinghe, Susan D Shenkin, et al.
Frontiers in Immunology|April 14, 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective studyEleanor Parker, Jordan Thomas, Kelly J Roper, et al.
Eclinicalmedicine|January 5, 2023
Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in MalawiUpendo L Mseka, Jonathan Mandolo, Kenneth Nyoni, et al.
The Lancet. Respiratory Medicine|May 17, 2021
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UKAnnemarie B Docherty, Rachel H Mulholland, Nazir I Lone, et al.
The Lancet Regional Health. Europe|August 13, 2021
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, Thomas M Drake, Ellen Pauley, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
BMJ Open|March 11, 2021
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocolLouise Sigfrid, Muge Cevik, Edwin Jesudason, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Cardiovascular Research|July 24, 2020
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) studyKenneth Mangion, Andrew Morrow, Catherine Bagot, et al.
The Lancet. Microbe|June 8, 2021
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort studyClark D Russell, Cameron J Fairfield, Thomas M Drake, et al.
BMJ (Clinical Research Ed.)|May 24, 2020
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyAnnemarie B Docherty, Ewen M Harrison, Christopher A Green, et al.
The Lancet. Digital Health|March 26, 2022
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort studyFiina Närhi, S Ramani Moonesinghe, Susan D Shenkin, et al.
Frontiers in Immunology|April 14, 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective studyEleanor Parker, Jordan Thomas, Kelly J Roper, et al.
Eclinicalmedicine|January 5, 2023
Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in MalawiUpendo L Mseka, Jonathan Mandolo, Kenneth Nyoni, et al.
The Lancet. Respiratory Medicine|May 17, 2021
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UKAnnemarie B Docherty, Rachel H Mulholland, Nazir I Lone, et al.
The Lancet Regional Health. Europe|August 13, 2021
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, Thomas M Drake, Ellen Pauley, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
BMJ Open|March 11, 2021
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocolLouise Sigfrid, Muge Cevik, Edwin Jesudason, et al.
Pageof 7